| Product Name | NebuSelect™ Recombinant Cynomolgus MCP-1/CCL2, His-tag |
|---|---|
| Catalog Number | NBL-241639 |
| Alias/Synonyms | MCP-1/CCL2 |
| Appearance | see COA |
| Molecule Weight | Gln24-Pro99 |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | P61274 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-241639-100ug | 100ug | Inquire | Inquire | |
| NBL-241639-1mg | 1mg | Inquire | Inquire | |
| NBL-241639-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Cynomolgus MCP-1/CCL2, His-tag
Catalog#:
NBL-241639
Description:
NebuSelect™ Recombinant Cynomolgus MCP-1/CCL2, His-tag(Cat#NBL-241639) is expressed in HEK293 with His tag at the C-Terminus.It contains Gln24-Pro99.
Species:
Cynomolgus
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 9.79 kDa. Due to glycosylation, the protein migrates to 13-16 kDa based on Bis-Tris PAGE result.
Target Name:
MCP-1/CCL2
Target Information:
Monocyte chemotactic protein-1 (MCP-1) (also referred to as chemokine (C-C motif) ligand 2 (CCL2) is expressed by mainly inflammatory cells and endothelial cells. MCP-1 has been reported to play an important role in the pathogenesis of atherosclerosis and considerable evidence supports that the monocyte containing MCPs and macrophage influences the growth of other cell types within the atherosclerotic lesion. This review will focus on the general structure features of MCP-1 and its role in atherosclerosis.
Amino Acid Sequence:
Gln24-Pro99
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.